Dual-target BCMA-CD19 CAR-T cell therapy

BCMA-CD19 CAR-T cells · Beijing GoBroad Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-target BCMA-CD19 CAR-T cell therapy, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration [Phase 1]